Greg Copenhaver, a UNC faculty member since 2001, was named director of the Institute for Convergent Science earlier this month.
The ICS, which focuses on problem-solving in science, will provide resources to people who are seeking to do research and will accelerate the research-to-commercialization process. It was approved by the Board of Trustees to be a University-wide institute in May. As such, ICS will be able to provide resources across the entire University.
Copenhaver, who serves as associate dean for research and innovation at the College of Arts & Sciences, said he is currently working on hiring the leadership team for the institute and getting the initial projects underway. He said the goal of the ICS is to identify societal needs and bring together people on campus who can address them.
“Usually, the way that the institute would do that is with some sort of innovation inflection point at the end of the process, and so sometimes that would be a commercialization event,” Copenhaver said. “So the team working on the problem might create a spin-out company that they would then take outside the University and deploy out in the real world, or it might be some other kind of inflection point.”
Sam Seyedin, associate director of ICS, was hired by Copenhaver.
He said he's very excited and focused on ICS's translation of research from the lab into the marketplace.
“So really, our hope is that ICS will bridge this gap on bringing resources and support to faculty, staff, students to really get where they need to go and in doing so, positioning them to be in the best space and environment to be the most successful,” Seyedin said.
Many projects are currently in development. Copenhaver said he is particularly excited about one of the institute's first AGILE projects.
AGILE, which stands for Advance Great Inventions or Leave Early, is a grant program. Copenhaver said that AGILE projects are larger funding packages that allow the institute to provide a couple hundred thousand dollars in funding over a period of 18 to 24 months.